Sangamo Therapeutics Announces Second Quarter 2022 Conference Call and Webcast

Rhea-AI Summary

Sangamo Therapeutics (NASDAQ: SGMO) has announced the release of its second quarter 2022 financial results, scheduled for August 4, 2022, after market close. A conference call to discuss these results will take place at 4:30 p.m. ET, open to the public. Participants are encouraged to register and join the call 10 minutes early for seamless access. A replay of the call will be available under the company's Events and Presentations section on its website, providing investors with insights into the company's financial performance and business developments.

BRISBANE, Calif.--(BUSINESS WIRE)-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the company has scheduled the release of its second quarter 2022 financial results after the market closes on Thursday, August 4, 2022.

The press release will be followed by a conference call at 4:30 p.m. ET, which will be open to the public. During the conference call, the company will review its financial results and provide business updates.

Participants should register for, and access, the call using this link. While not required, it is recommended to join 10 minutes prior to the event start. Once registered, participants will be given the option to either dial into the call with the number and unique passcode provided, or to use the dial-out option to connect their phone instantly. The link to access the live webcast can also be found on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations.

A replay will be available following the conference call, accessible under Events and Presentations.

About Sangamo Therapeutics

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, cell therapy, and genome engineering. For more information about Sangamo, visit www.sangamo.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220728005792/en/

Investor & Media Inquiries

Louise Wilkie

ir@sangamo.com

media@sangamo.com

Source: Sangamo Therapeutics, Inc.

FAQ

When will Sangamo Therapeutics release its Q2 2022 financial results?

Sangamo Therapeutics will release its Q2 2022 financial results on August 4, 2022, after market close.

What time is the conference call for Sangamo Therapeutics Q2 2022 results?

The conference call for Sangamo Therapeutics Q2 2022 results is scheduled for 4:30 p.m. ET on August 4, 2022.

How can I access the Sangamo Therapeutics conference call?

You can access the Sangamo Therapeutics conference call by registering through the provided link or joining via the dial-in number after registration.

Where can I find the replay of Sangamo Therapeutics conference call?

The replay of the Sangamo Therapeutics conference call will be available in the Events and Presentations section on their website.